Silvergate资本 SI 深 沪
等待开盘 12-16 09:30:00 美东时间
14.635
+0.265
+1.84%
华盛通- 最 高14.675
- 今 开14.675
- 成交量 2.63万股
- 最 低 14.07
- 昨 收 14.37
- 总市值 3.02亿
- 52周最高 17.94
- 市盈率 静 --
- 换手率 0.13%
- 52周最低 10.92
- 委 比 50.98%
- 总股本 2060.17万
- 历史最高 17.94
- 量 比 0.72
- 振 幅 4.21%
- 历史最低 10.92
- 每 手 1
- 风险率 1.42%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Russell 2000 Hits Record Highs, Silver Rallies To $60: What's Moving Markets Tuesday?
U.S. small caps climbed to fresh record highs Tuesday as traders nearly fully priced in a Federal Reserve rate cut at Wednesday's policy meeting.
12-10 02:00
Silver's Historic Run Supercharges ETF Demand As Inventories Run Thin
Silver is near an all-time high. Last week saw the largest inflows into silver-backed ETFs since July, adding nearly 590 tons of metal.
12-09 01:21
美股大行评级 | 最高500美元！MongoDB获18家大行紧急上调目标价；巴克莱下调理想汽车目标价至18美元
今日重点评级关注：B. Riley证券：维持Seabridge Gold"买入"评级，目标价从50美元升至65美元；HC Wainwright & Co.：维持TRX Gold"买入"评级，目标价从1.2美元升至1.4美元
12-03 09:58
Morgan Stanley Maintains Overweight on Shoulder Innovations, Raises Price Target to $23
Morgan Stanley analyst Manan Gosalia maintains Shoulder Innovations (NYSE:SI) with a Overweight and raises the price target from $18 to $23.
12-03 01:53
美股大行评级 | 富国银行上调AMD目标价升至345美元；花旗上调礼来目标价升至1500美元；巴克莱上调腾讯音乐目标价升至28美元
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从12美元升至15美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从106美元升至107美元
11-13 09:58
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Leap Therapeutics (NASDAQ:LPTX) stock moved upwards by 176.6% to $1.21...
11-13 01:05
Piper Sandler Reiterates Overweight on Shoulder Innovations, Maintains $18 Price Target
Piper Sandler analyst Matt O'Brien reiterates Shoulder Innovations (NYSE:SI) with a Overweight and maintains $18 price target.
11-13 01:05
Shoulder Innovations (SI) Stock Rose 21% After-Hours: Here's Why
Shoulder Innovations shares jumped more than 21% in after-hours trading Tuesday after the company posted strong quarterly results and raised its 2025 revenue forecast.
11-12 15:33
Shoulder Innovations Raises FY2025 Sales Guidance from $42.000M-$44.000M to $45.000M-$46.000M vs $43.173M Est
Shoulder Innovations (NYSE:SI) raises FY2025 sales outlook from $42.000 million-$44.000 million to $45.000 million-$46.000 million vs $43.173 million estimate.
11-12 06:45
Shoulder Innovations shares are trading higher after the company reported better-than-expected Q3 sales results.
Shoulder Innovations shares are trading higher after the company reported bette...
11-12 05:14
